MediciNova Correlations

MNOV Stock  USD 1.33  0.04  2.92%   
The current 90-days correlation between MediciNova and Apellis Pharmaceuticals is -0.01 (i.e., Good diversification). The correlation of MediciNova is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

MediciNova Correlation With Market

Average diversification

The correlation between MediciNova and NYA is 0.12 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and NYA in the same portfolio, assuming nothing else is changed.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MediciNova. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy MediciNova Stock please use our How to Invest in MediciNova guide.

Moving against MediciNova Stock

  0.34MYMD MyMD PharmaceuticalsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
DRMAAPLS
DRMAABOS
ABOSAPLS
DRMADAWN
ABOSDAWN
TERNAPLS
  
High negative correlations   
TERNXFOR
TERNDAWN

Risk-Adjusted Indicators

There is a big difference between MediciNova Stock performing well and MediciNova Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze MediciNova's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

MediciNova Corporate Management

Jason CPACFO OfficerProfile
Dr MBAChief OfficerProfile
Yuichi MDPresident, CoFounderProfile
MD MPHChief DirectorProfile
John CPAControllerProfile